![Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer]()
Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancerUriarte-Pinto, Moisés; Escolano-Pueyo, Ángel; Gimeno-Ballester, Vicente; Pascual-Martínez, Oihana; Abad-Sazatornil, María Reyes; Agustín-Ferrández, María José · International Journal of Clinical Pharmacy · 2016